Want to see PBSV full AI Analyst Report?
Pharma Bio Services (PBSV) Income Statement
Pharma Bio Services Income Statement
Last quarter (Q3 2026), Pharma Bio Services's total revenue was $2.34M, an increase of 19.00% from the same quarter last year. In Q3, Pharma Bio Services's net income was $-14.22M. See Pharma Bio Services’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Oct 25 | Oct 24 | Oct 23 | Oct 22 | Jan 22 |
|---|---|---|---|---|---|
| $ 9.00M | $ 9.51M | $ 16.98M | $ 19.40M | $ 20.12M | |
| $ 2.91M | $ 2.52M | $ 5.07M | $ 4.88M | $ 5.36M | |
| $ 3.55M | $ 3.80M | $ 3.95M | $ 3.71M | $ 9.21M | |
| Depreciation and Amortization | $ 229.07K | $ 181.16K | $ 194.32K | $ 51.11K | $ 72.73K |
| $ 134.81K | $ -1.11M | $ 1.31M | $ 1.23M | $ -3.78M | |
| $ -637.66K | $ -1.29M | $ 1.12M | $ 1.17M | $ -3.85M | |
| $ 543.40K | $ 532.14K | $ 570.08K | $ 13.42K | $ 1.98M | |
| $ -94.26K | $ -755.45K | $ 1.69M | $ 1.19M | $ -1.88M | |
| $ -100.46K | $ -777.62K | $ 1.31M | $ 1.01M | $ -2.09M | |
| Per Share Metrics | |||||
| Basic EPS | $ -0.00 | $ -0.03 | $ 0.06 | $ 0.04 | $ -0.09 |
| Diluted EPS | $ -0.00 | $ -0.03 | $ 0.06 | $ 0.04 | $ -0.09 |
| Weighted Average Shares Outstanding | 22.95M | 22.97M | 22.97M | 23.00M | 23.03M |
| Weighted Average Shares Outstanding (Diluted) | 22.96M | 22.97M | 23.00M | 23.03M | 23.03M |
Currency in USD